Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Green, Traci C ^a,b   Black, Ryan ^c   Serrano, Jill M ^c   Budman, Simon H ^c   Butler, Stephen F ^c  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c INFLEXXION INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; BUTORPHANOL; BUTORPHANOL TARTRATE; CODEINE; DEXTROPROPOXYPHENE; FENTANYL; FENTANYL CITRATE; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; ILLICIT DRUG; METHADONE; MORPHINE; MORPHINE SULFATE; OPANA IR; OPIATE; OXYCODONE; OXYMORPHONE; PARACETAMOL; PENTAZOCINE; PERCOCET; PETHIDINE; TRAMADOL; TYLOX; ULRACET; UNCLASSIFIED DRUG; UTRAM; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; CRIMINAL JUSTICE; DATA ANALYSIS; DRUG DEPENDENCE; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRESCRIPTION; RACE; RISK FACTOR; SEX DIFFERENCE; SUBSTANCE ABUSE; ADDICTION; ADOLESCENT; INFORMATION PROCESSING; MIDDLE AGED; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; DATA COLLECTION; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; PRESCRIPTION DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 80355136553     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027244     Document Type: Article

References (83)

1. Dasgupta N, Kramer ED, Zalman MA, Carino S, Smith MY, et al. (2006) Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend 82: 135-142.
2. Wisniewski AM, Purdy CH, Blondell RD, (2008) The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J Addict Dis 27: 1-11.
3. Goodman FD, Glassman P, (2005) Evaluating potentially aberrant outpatient prescriptions for extended-release oxycodone. Am J Health Syst Pharm 62: 2604-2608.
4. NSDUH (2007) 2007 National Survey on Drug Use & Health:National Results. Rockville, MD Substance Abuse Mental Health Services Administration.
5. Paulozzi LJ, (2008) Trends in Unintentional Drug Overdose Deaths. Subcommittee on Crime & Drugs Committee on the Judiciary and the Caucus on International Narcotics Control United States Senate Washington, D.C.
6. Grau LE, Dasgupta N, Harvey AP, Irwin K, Givens A, et al. (2007) Illicit use of opioids: is OxyContin a "gateway drug"? Am J Addict 16: 166-173.
7. Daniulaityte RV, Carlson RG, Kenne DR, (2006) Initiation to pharmaceutical opioids and patterns of misuse: Preliminary qualitative findings obstained by the Ohio Substance Abuse Monitoring Network. Journal of Drug Issues pp. 787-808.
8. Paulozzi LJ, (2007) Trends in Unintentional Drug Poisoning Deaths. Committee on Energy & Commerce, Subcommittee on Oversight & Investigations, United States House of Representatives. Washington, D.C.
9. Girion L, Glover S, Smith D, (2011) Drug deaths now outnumber traffic fatalities in U.S., data show. Los Angeles Times. Los Angeles, CA.
10. Kochanek KD, Xu J, Murphy SL, Miniño AM, Kung HC, (2011) Deaths: Preliminary Data for 2009. Hyattsville, MD National Center for Health Statistics.
11. Paulozzi LJ, Budnitz DS, Xi Y, (2006) Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 15: 618-627.
12. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, et al. (2008) Patterns of abuse among unintentional pharmaceutical overdose fatalities. Journal of the American Medical Association 200: 2613-2620.
13. Boyd CJ, Esteban McCabe S, Teter CJ, (2006) Medical and nonmedical use of prescription pain medication by youth in a Detroit-area public school district. Drug Alcohol Depend 81: 37-45.
14. McCabe SE, Boyd CJ, Teter CJ, (2005) Illicit use of opioid analgesics by high school seniors. J Subst Abuse Treat 28: 225-230.
15. McCabe SE, Boyd CJ, Young A, (2007) Medical and nonmedical use of prescription drugs among secondary school students. J Adolesc Health 40: 76-83.
16. Simoni-Wastila L, Yang HK, (2006) Psychoactive drug abuse in older adults. Am J Geriatr Pharmacother 4: 380-394.
17. Simoni-Wastila L, Ritter G, Strickler G, (2004) Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse 39: 1-23.
18. Green TC, Grimes Serrano JM, Licari A, Budman SH, Butler SF, (2009) Women who abuse prescritpion opioids: Findings from the National Addictions Viligance Intervention and Prevention Program. Drug Alcohol Depend 103: 65-73.
19. Butler SF, Budman SH, Fernandez K, Jamison RN, (2004) Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 112: 65-75.
20. Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN, (2008) Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain 9: 360-372.
21. Manchikanti L, Cash KA, Damron KS, Manchukonda R, Pampati V, et al. (2006) Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables. Pain Physician 9: 215-225.
22. Davis WR, Johnson BD, (2008) Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend 92: 267-276.
23. Butler SF, Budman SH, Licari A, Cassidy TA, Lioy K, et al. (2008) National Addictions Vigilance Intervention and Prevention Program (NAVIPPRO™): A real-time, product-specific, public health surveillance system for monitoring prescription drug abuse Pharmacoepidemiology and Drug Safety 17: 1142-1154.
24. Hendricks VM, Kaplan CD, VanLimbeek J, Geerlings P, (1989) The Addiction Severity Index: Reliability and validity in a Dutch addict population. Journal of Substance Abuse Treatment 6: 133-141.
25. McLellan AT, Kushner H, Metzger D, Peters R, (1992) The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 9: 199-213.
26. Gossop M, (1992) Addiction: treatment and outcome. J R Soc Med 85: 469-472.
27. McCabe SE, Cranford JA, Boyd CJ, Teter CJ, (2007) Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict Behav 32: 562-575.
28. Chitwood DD, Comerford M, Sanchez J, (2003) Prevalence and risk factors for HIV among sniffers, short-term injectors, and long-term injectors of heroin. J Psychoactive Drugs 35: 445-453.
29. Stohler R, Dursteler-Mac Farland KM, Gramespacher C, Petitjean S, Battegay R, et al. (2000) A comparison of heroin chasers with heroin injectors in Switzerland. Eur Addict Res 6: 154-159.
30. Latkin CA, Knowlton AR, Sherman S, (2001) Routes of drug administration, differential affiliation, and lifestyle stability among cocaine and opiate users: implications to HIV prevention. J Subst Abuse 13: 89-102.
31. Razak MH, Jittiwutikarn J, Suriyanon V, Vongchak T, Srirak N, et al. (2003) HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs. J Acquir Immune Defic Syndr 33: 259-266.
32. McLellan AT, Luborsky L, Woody GE, O'Brien CP, (1980) An improved diagnostic evaluation instrument for substance abuse patients. Journal of Nervous and Mental Disease 168: 26-33.
33. Muthen B, (2004) Latent variable analysis: Growth mixture modeling and related techniques for longitudinal data. In: Kaplan D, editors. Handbook of Quantitative Methodology for the Social Sciences Newbury Park, CA Sage Publications pp. 345-368.
34. Muthen LK, Muthen B, (2007) Mplus User's Guide. Los Angeles Muthen & Muthen.
35. Agrawal A, Lynskey MT, Madden PAF, Bucholz KK, Heath AC, (2006) A latent class analysis of illicit drug abuse/dependence: results from the National Epidemiological Survery on Alcohol and Related Conditions. Addiction 102: 94-104.
36. Monga N, Rehm J, Fischer B, Brissette S, Bruneau J, et al. (2007) Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend 88: 1-8.
37. Nylund KL, Asparouhov T, Muthen B, (2007) Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study. Structural Equation Modeling 14: 535-569.
38. Delucchi KL, Matzger H, Weisner C, (2004) Dependent and problem drinking over 5 years: a latent class growth analysis. Drug Alcohol Depend 74: 235-244.
39. Hickman M, Lingford-Hughes A, Bailey C, Macleod J, Nutt D, et al. (2008) Does alcohol increase the risk of overdose death: the need for a translational approach. Addiction 103: 1060-1062.
40. Warner-Smith M, Darke S, Lynskey M, Hall W, (2001) Heroin overdose: causes and consequences. Addiction 96: 1113-1125.
41. Shah NG, Lathrop SL, Reichard RR, Landen MG, (2007) Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addiction 103: 126-136.
42. Wang C, Vlahov D, Galai N, Cole SR, Bareta J, et al. (2005) The effect of HIV infection on overdose mortality. AIDS 19: 935-942.
43. Chaisson RE, Moss AR, Onishi R, Osmond D, Carlson JR, (1987) Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. American Journal of Public Health 77: 169-172.
44. Marmor M, DesJarlais DC, Cohen H, Friedman SR, Beatrice ST, et al. (1987) Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1: 39-44.
45. Substance Abuse and Mental Health Services Administration (2008) Treatment Episode Data Set (TEDS) 1996-2006. National admissions to substance abuse treatment services Rockville, MD Department of Health and Human Services.
46. Ghandour LA, Martins SS, Chilcoat HD, (2008) Understanding the patterns and distribution of opioid analgesic dependence symptoms using a latent empirical approach. International Journal of Methods in Psychiatric Research 17: 89-103.
47. Wu LT, Woody GE, Yang C, Blazer DG, (2010) Subtypes of nonmedical opioid users: Results from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend 112: 69-80.
48. McCabe SE, Boyd CJ, Teter CJ, (2009) Subtypes of nonmedical prescription drug misuse. Drug and Alcohol Dependence 102: 63-70.
49. Jamison RN, Kauffman J, Katz NP, (2000) Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 19: 53-62.
50. Potter JS, Hennessy G, Borrow JA, Greenfield SF, Weiss RD, (2004) Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug Alcohol Depend 76: 213-215.
51. Office of Applied Studies (2004) Results from the 2003 National Survey on Drug Use and Health: National Findings. Substance Abuse and Mental Health Services Administration.
52. Passik SD, Hays L, Eisner N, Kirsh KL, (2006) Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation. J Pain Palliat Care Pharmacother 20: 5-13.
53. Morasco BJ, Gritzner S, Lewis L, Oldham R, Turk DC, et al. (2011) Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder Pain 152: 488-497.
54. Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, et al. (2008) Gender and non-medical use of prescription opioids: results from a national US survey*. Addiction 103: 258-268.
55. Back SE, Payne RL, Simpson AN, Brady KT, (2010) Gender and prescription opioids: Findings from the National Survey on Drug Use and Health. Addictive Behaviors 35: 1001-1007.
56. Huang B, Dawson DA, Stinson FS, Hasin DS, Ruan WJ, et al. (2006) Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67: 1062-1073.
57. McCabe SE, Teter CJ, Boyd CJ, Knight JR, Wechsler H, (2005) Nonmedical use of prescription opioids among U.S. college students: Prevalence and correlates from a national survey. Addictive Behaviors 30: 789-805.
58. McCabe SE, Knight JR, Teter CJ, Wechsler H, (2005) Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100: 96-106.
59. McCabe SE, Teter CJ, Boyd CJ, (2005) Illicit use of prescription pain medication among college students. Drug and Alcohol Dependence 77: 37-47.
60. Teter CJ, McCabe SE, Cranford JA, Boyd CJ, Guthrie SK, (2005) Prevalence and Motives for Illicit Use of Prescription Stimulants in an Undergraduate Student Sample. Journal of American College Health 53: 253-262.
61. Lord S, Downs G, Furtaw P, Chaudhuri A, Silverstein A, et al. (2003) Nonmedical use of prescription opioids and stimulants among student pharmacists. J Am Pharm Assoc 49: 519-528.
62. McCabe SE, Boyd CJ, Cranford JA, Teter CJ, (2009) Motives for Nonmedical Use of Prescription Opioids Among High School Seniors in the United States: Self-treatment and Beyond. Arch Pediatr Adolesc Med 163: 739-744.
63. Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Heckathorn DD, et al. (2007) The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction 102: 778-785.
64. Havens JR, Oser CB, Knudsen HK, Lofwall M, Stoops WW, et al. (2011) Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend 115: 107-112.
65. Draus PJ, Carlson RG, (2006) Needles in the Haystacks: The Social Context of Initiation to Heroin Injection in Rural Ohio. Substance Use & Misuse 41: 1111-1124.
66. Gossop M, Griffiths P, Powis B, Strang J, (1992) Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict 87.
67. Carise D, Dugosh KL, McLellan AT, Camilleri A, Woody GE, et al. (2007) Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry 164: 1750-1756.
68. Havens JR, Simmons LA, Oser CB, Shannon LM, (2008) Characterizing opioid analgesic injectors: Results from a national sample. College on Problems of Drug Dependence. San Juan, PR.
69. McNees E, Stanton-Tindall M, Leukefeld CG, Walker R, Rees J, (2008) An exploratory profile of illicit prescription opiate users by route of administration. San Juan, PR.
70. Havens JR, Walker R, Leukefeld CG, (2008) Prescription opioid use in the rural Appalachia: a community-based study. J Opioid Manag 4: 63-71.
71. Shah NG, Lathrop SL, Reichard RR, Landen MG, (2008) Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addiction 103: 126-136.
72. Office of National Drug Control Policy (2011) Epidemic: Responding to America's Prescription Drug Abuse Crisis.
73. FDA, (2011) Questions and Answers: FDA Requires a Risk Evaluation and Mitigation Strategy (REMS) for Long-Acting and Extended-Release Opioids.
74. Green TC, Heimer R, Grau LE, (2008) Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Blackwell Publishing Ltd pp. 979-989.
75. Doe-Simkins M, Walley AY, Epstein A, Moyer P, (2009) Saved by the Nose: Bystander-Administered Intranasal Naloxone Hydrochloride for Opioid Overdose. Am J Public Health 99: 788-791.
76. Dasgupta N, Sanford C, Albert S, Wells Brason F, (2010) Opioid Drug Overdoses: A Prescription for Harm and Potential for Prevention. American Journal of Lifestyle Medicine 4: 32-37.
77. Connors GJ, Maisto SA, (2003) Drinking reports from collateral individuals. Addiction 98 (Suppl 2): 21-29.
78. Del Boca FK, Darkes J, (2003) The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction 98 (Suppl 2): 1-12.
79. Neale J, Robertson M, (2003) Comparisons of self-report data and oral fluid testing in detecting drug use amongst new treatment clients. Drug Alcohol Depend 71: 57-64.
80. Secades-Villa R, Fernandez-Hermida JR, (2003) The validity of self-reports in a follow-up study with drug addicts. Addict Behav 28: 1175-1182.
81. Yacoubian GS Jr, Urbach BJ, (2002) To pee or not to pee: reconsidering the need for urinalysis. J Drug Educ 32: 261-270.
82. Solbergsdottir E, Bjornsson G, Gudmundsson LS, Tyrfingsson T, Kristinsson J, (2004) Validity of self-reports and drug use among young people seeking treatment for substance abuse or dependence. J Addict Dis 23: 29-38.
83. United States Department of Health and Human Services (2009) Treatment Episode Data Set - Admissions (TEDS-A). Substance Abuse and Mental Health Services Administration OoAS, editor. ICPSR30462-v1 ed. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor].